Shifts in Japan’s Life Science and Health Care Policy
Yuji Yamamoto (MinaCare) discusses Japan’s revised policies toward its life science sector and assesses the government’s new efforts to leverage the sector as a key driver of economic growth.
A Chinese Perspective on National Life Science Innovation and Leadership
Yiwu He (Bill & Melinda Gates Foundation) compares and contrasts the environments for innovation in the life sciences in the United States and China. He argues that China’s life science sector is likely to benefit over the long term from significant financial investments from the government and private funds that allow for R&D failures over the short term.
Healthcare and Life Sciences Industry as a Strategic Focus for South Korea
South Korea's President Park Geun-hye has endorsed healthcare as a strategic industry for South Korea. Joo Hun You (South Korea's Ministry of Health and Welfare) discusses the relationship between the country’s domestic health industry and healthcare system and implications of this endorsement for the U.S.–South Korea strategic relationship.
The Value of Product Development Partnerships
A product development partnership (PDP) is a 21st-century nonprofit organizational structure that enables the public, private, academic, and philanthropic sectors to aggregate funding for the development of drugs, vaccines, and other health tools as public goods. Rob Lin, Vice President of Finance at the Infectious Diseases Research Institute (IDRI), about the value of the PDP model to global health R&D, criticisms of the model, and its significance for the U.S.-Asia relationship.
Sino-U.S. Relations Through a Life Sciences Prism
Yanzhong Huang (Council on Foreign Relations) analyzes China's policies toward its life sciences sector and considers their impact on political and economic relations with other Asian countries and the United States.
Page: 1 of 4
TB in 2014: Reasons for Optimism and Vigilance
Despite substantial progress in preventing, diagnosing, and treating tuberculosis (TB), the disease continues to pose a grave threat to health in the Asia-Pacific and worldwide. In advance of World TB Day (March 24), NBR spoke with Dr. Mario Raviglione (World Health Organization) about recent developments in fighting this disease.